Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 3, 2011, Pages 369-376

  Hoegl, Sandra ^a,b   Bachmann, Malte ^b   Scheiermann, Patrick ^a   Goren, Itamar ^b   Hofstetter, Christian ^c   Pfeilschifter, Josef ^b   Zwissler, Bernhard ^a   Muhl, Heiko ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aerosol; IL 22; Inflammation; Lung; Ventilator induced lung injury

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSISTED VENTILATION; BAROTRAUMA; CELL STRESS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SURVIVAL; VENTILATOR INDUCED LUNG INJURY;

AEROSOLS; ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKINS; LUNG; LUNG NEOPLASMS; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR; VENTILATOR-INDUCED LUNG INJURY;

RATTUS;

EID: 79952217505     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0440OC     Document Type: Article

References (48)

1. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10- related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000;97:10144-10149.
2. Wolk K, Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006;17:367-380. (Pubitemid 44572879)
3. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006;203:2271-2279. (Pubitemid 44498362)
4. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007;8:950-957. (Pubitemid 47300009)
5. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007;27:647-659. (Pubitemid 47615503)
6. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, et al. IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nat Med 2008;14:275-281. (Pubitemid 351347908)
7. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008;14:282-289. (Pubitemid 351347912)
8. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld JC, Matthys P. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009;60:390-395.
9. Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008;118:597-607. (Pubitemid 351206549)
10. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332-1342. (Pubitemid 38569055)
11. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008;118:534-544. (Pubitemid 351206544)
12. Lionetti V, Recchia FA, Ranieri VM. Overview of ventilator-induced lung injury mechanisms. Curr Opin Crit Care 2005;11:82-86. (Pubitemid 40227476)
13. Uhlig S, Uhlig U. Pharmacological interventions in ventilator-induced lung injury. Trends Pharmacol Sci 2004;25:592-600. (Pubitemid 39371150)
14. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003;14:523-535. (Pubitemid 37296025)
15. Narimanbekov IO, Rozycki HJ. Effect of IL-1 blockade on inflammatory manifestations of acute ventilator-induced lung injury in a rabbit model. Exp Lung Res 1995;21:239-254.
16. Imai Y, Kawano T, Iwamoto S, Nakagawa S, Takata M, Miyasaka K. Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits. J Appl Physiol 1999;87:510-515. (Pubitemid 29374983)
17. Hoegl S, Boost KA, Czerwonka H, Dolfen A, Scheiermann P, Muhl H, Zwissler B, Hofstetter C. Inhaled IL-10 reduces biotrauma and mortality in a model of ventilator-induced lung injury. Respir Med 2009;103(3):463-470.
18. Hofstetter C, Flondor M, Hoegl S, Thein E, Kemming G, Kisch-Wedel H, Kreyling W, Zwissler B. Aerosol delivery during mechanical ventilation to the rat. Exp Lung Res 2004;30:635-651. (Pubitemid 39202405)
19. Lim CM, Hong SB, Koh Y, Lee SD, Kim WS, Kim DS, Kim WD. Hypothermia Attenuates Vascular Manifestations of ventilator-induced lung injury in rats. Lung 2003;181:23-34. (Pubitemid 36951925)
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
21. Nold M, Goede A, Eberhardt W, Pfeilschifter J, Muhl H. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. Naunyn Schmiedebergs Arch Pharmacol 2003;367:68-75. (Pubitemid 36207683)
22. Whittington HA, Armstrong L, Uppington KM, Millar AB. Interleukin-22: a potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol 2004;31:220-226. (Pubitemid 39095452)
23. Heuze-Vourc'h N, Zhu L, Krysan K, Batra RK, Sharma S, Dubinett SM. Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells. Cancer Res 2003;63:766-770.
24. Lim S, Caramori G, Tomita K, Jazrawi E, Oates T, Chung KF, Barnes PJ, Adcock IM. Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. Allergy 2004;59:505-514. (Pubitemid 38580770)
25. Williams L, Bradley L, Smith A, Foxwell B. Signal transducer and activator of transcription 3 is the dominant mediator of the antiinflammatory effects of IL-10 in human macrophages. J Immunol 2004;172:567-576. (Pubitemid 38020514)
26. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007;178:2623-2629. (Pubitemid 46333135)
27. Niemand C, Nimmesgern A, Haan S, Fischer P, Schaper F, Rossaint R, Heinrich PC, Muller-Newen G. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3. J Immunol 2003;170:3263-3272. (Pubitemid 36302204)
28. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007;7:454-465. (Pubitemid 46834848)
29. Chiumello D, Pristine G, Slutsky AS. Mechanical ventilation affects local and systemic cytokines in an animal model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1999;160:109-116. (Pubitemid 29326075)
30. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, Iwakura Y, Sakaguchi N, Sakaguchi S. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-171 Th cells that cause autoimmune arthritis. J Exp Med 2007;204:41-47. (Pubitemid 46148754)
31. Dos Santos CC, Slutsky AS. The contribution of biophysical lung injury to the development of biotrauma. Annu Rev Physiol 2006;68:585-618.
32. Tremblay LN, Slutsky AS. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 1998;110:482-488. (Pubitemid 28516123)
33. Vlahakis NE, Hubmayr RD. Response of alveolar cells to mechanical stress. Curr Opin Crit Care 2003;9:2-8. (Pubitemid 36152935)
34. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS. Injurious ventilatory strategies increase cytokines and C-Fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997;99:944-952. (Pubitemid 27123631)
35. Haitsma JJ, Uhlig S, Goggel R, Verbrugge SJ, Lachmann U, Lachmann B. Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha. Intensive Care Med 2000;26:1515-1522.
36. Vreugdenhil HA, Haitsma JJ, Jansen KJ, Zijlstra J, Plotz FB, Van Dijk JE, Lachmann B, Van Vught H, Heijnen CJ. Ventilator-induced heat shock protein 70 and cytokine mRNA expression in a model of lipopolysaccharide-induced lung inflammation. Intensive Care Med 2003;29:915-922. (Pubitemid 36783161)
37. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-1308.
38. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282:54-61. (Pubitemid 29318933)
39. Hokuto I, Ikegami M, Yoshida M, Takeda K, Akira S, Perl AK, Hull WM, Wert SE, Whitsett JA. STAT-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest 2004;113:28-37. (Pubitemid 38541629)
40. Matsuzaki Y, Xu Y, Ikegami M, Besnard V, Park KS, Hull WM, Wert SE, Whitsett JA. STAT3 is required for cytoprotection of the respiratory epithelium during adenoviral infection. J Immunol 2006;177:527-537. (Pubitemid 43939166)
41. Lian X, Qin Y, Hossain SA, Yang L, White A, Xu H, Shipley JM, Li T, Senior RM, Du H, et al. Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. J Immunol 2005;174:7250-7256. (Pubitemid 40705694)
42. Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering rna on human lung cancer xenografts. Clin Cancer Res 2008;14:6432-6439.
43. Xu Y, Ikegami M, Wang Y, Matsuzaki Y, Whitsett JA. Gene expression and biological processes influenced by deletion of STAT3 in pulmonary type II epithelial cells. BMC Genomics 2007;8:455.
44. Lu Y, Fukuyama S, Yoshida R, Kobayashi T, Saeki K, Shiraishi H, Yoshimura A, Takaesu G. Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic. J Biol Chem 2006;281:36683-36690. (Pubitemid 46042135)
45. Ronn SG, Borjesson A, Bruun C, Heding PE, Frobose H, Mandrup-Poulsen T, Karlsen AE, Rasschaert J, Sandler S, Billestrup N. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection. Diabetologia 2008;51:1873-1882.
46. Sutherland KD, Vaillant F, Alexander WS, Wintermantel TM, Forrest NC, Holroyd SL, McManus EJ, Schutz G, Watson CJ, Chodosh LA, et al. C-Myc as a mediator of accelerated apoptosis and involution in mammary glands lacking SOCS3. EMBO J 2006;25:5805-5815. (Pubitemid 44967764)
47. Le A, Damico R, Damarla M, Boueiz A, Pae HH, Skirball J, Hasan E, Peng X, Chesley A, Crow MT, et al. Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol 2008;105:1282-1290.
48. Li LF, Liao SK, Lee CH, Tsai YH, Huang CC, Quinn DA. Ventilationinduced neutrophil infiltration and apoptosis depend on apoptosis signal-regulated kinase 1 pathway. Crit Care Med 2005;33:1913-1921. (Pubitemid 41306509)